Keyphrases
Gut Commensal Microbiota
100%
Rifaximin
100%
Toll-like
50%
Immune Markers
25%
Clostridium
12%
Immune System
12%
Quantitative PCR
12%
Fluorescence in Situ Hybridization
12%
Control Condition
12%
Toll-like Receptor 2 (TLR2)
12%
Modulatory
12%
Symptomatology
12%
Total Bacterial Count
12%
Antibacterial Properties
12%
Broad-spectrum Antibiotics
12%
Microbial Profile
12%
Treatment Duration
12%
Bacterial Diversity
12%
Bifidobacterium
12%
Receptor Expression
12%
Colonic Epithelium
12%
Healthy Mice
12%
Functional Gastrointestinal Disorders
12%
Minor Change
12%
Bacteroides Sp
12%
Terminal Restriction Fragment Length Polymorphism
12%
C57BL/6NCrl
12%
Tory
12%
Medicine and Dentistry
Rifaximin
100%
Gut
100%
Toll Like Receptor
37%
Immunity
25%
Immune System
12%
Toll Like Receptor 4
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Upregulation
12%
Symptomatology
12%
Broad-Spectrum Antibiotic
12%
Bifidobacterium
12%
Clostridium
12%
Receptor Expression
12%
Functional Gastrointestinal Disorder
12%
Fluorescence in Situ Hybridization
12%
Bacteroides
12%
Toll Like Receptor 2
12%
Restriction Fragment Length Polymorphism
12%
Antibacterial Activity
12%